z-logo
open-access-imgOpen Access
The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
Author(s) -
Shelby M. Knoche,
Gabrielle L. Brumfield,
Benjamin T. Goetz,
Bailee H. Sliker,
Alaina C. Larson,
Madeline T Olson,
Brittany Poelaert,
Audrey Bavari,
Ying Yan,
Jennifer D. Black,
Joyce C. Solheim
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0273518
Subject(s) - vorinostat , pancreatic cancer , gemcitabine , histone deacetylase inhibitor , cancer research , histone deacetylase , cancer , medicine , biology , pharmacology , histone , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here